175 related articles for article (PubMed ID: 23423643)
1. Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis.
Potikha T; Stoyanov E; Pappo O; Frolov A; Mizrahi L; Olam D; Shnitzer-Perlman T; Weiss I; Barashi N; Peled A; Sass G; Tiegs G; Poirier F; Rabinovich GA; Galun E; Goldenberg D
Hepatology; 2013 Jul; 58(1):192-204. PubMed ID: 23423643
[TBL] [Abstract][Full Text] [Related]
2. Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model.
Potikha T; Pappo O; Mizrahi L; Olam D; Maller SM; Rabinovich GA; Galun E; Goldenberg DS
FASEB J; 2019 Jul; 33(7):7995-8007. PubMed ID: 30897344
[TBL] [Abstract][Full Text] [Related]
3. Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice.
Barashi N; Weiss ID; Wald O; Wald H; Beider K; Abraham M; Klein S; Goldenberg D; Axelrod J; Pikarsky E; Abramovitch R; Zeira E; Galun E; Peled A
Hepatology; 2013 Sep; 58(3):1021-30. PubMed ID: 23526353
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
[TBL] [Abstract][Full Text] [Related]
5. Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice.
Katzenellenbogen M; Pappo O; Barash H; Klopstock N; Mizrahi L; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Mitchell LA; Kohen R; Domany E; Galun E; Goldenberg D
Cancer Res; 2006 Apr; 66(8):4001-10. PubMed ID: 16618719
[TBL] [Abstract][Full Text] [Related]
6. The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma.
Gamaev L; Mizrahi L; Friehmann T; Rosenberg N; Pappo O; Olam D; Zeira E; Bahar Halpern K; Caruso S; Zucman-Rossi J; Axelrod JH; Galun E; Goldenberg DS
Oncogene; 2021 Jan; 40(1):127-139. PubMed ID: 33093654
[TBL] [Abstract][Full Text] [Related]
7. Specific genomic and transcriptomic aberrations in tumors induced by partial hepatectomy of a chronically inflamed murine liver.
Ella E; Heim D; Stoyanov E; Harari-Steinfeld R; Steinfeld I; Pappo O; Perlman TS; Nachmansson N; Rivkin L; Olam D; Abramovitch R; Wege H; Galun E; Goldenberg D
Oncotarget; 2014 Nov; 5(21):10318-31. PubMed ID: 25401338
[TBL] [Abstract][Full Text] [Related]
8. Chronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis.
Stoyanov E; Ludwig G; Mizrahi L; Olam D; Schnitzer-Perlman T; Tasika E; Sass G; Tiegs G; Jiang Y; Nie T; Kohler J; Schinazi RF; Vertino PM; Cedar H; Galun E; Goldenberg D
Oncotarget; 2015 May; 6(13):11047-60. PubMed ID: 25918251
[TBL] [Abstract][Full Text] [Related]
9. HCV tumor promoting effect is dependent on host genetic background.
Klopstock N; Katzenellenbogen M; Pappo O; Sklair-Levy M; Olam D; Mizrahi L; Potikha T; Galun E; Goldenberg D
PLoS One; 2009; 4(4):e5025. PubMed ID: 19340302
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model.
Zahavi T; Lanton T; Divon MS; Salmon A; Peretz T; Galun E; Axelrod JH; Sonnenblick A
Oncotarget; 2016 Jan; 7(4):4860-70. PubMed ID: 26695439
[TBL] [Abstract][Full Text] [Related]
11. p21 promotes sustained liver regeneration and hepatocarcinogenesis in chronic cholestatic liver injury.
Marhenke S; Buitrago-Molina LE; Endig J; Orlik J; Schweitzer N; Klett S; Longerich T; Geffers R; Sánchez Muñoz A; Dorrell C; Katz SF; Lechel A; Weng H; Krech T; Lehmann U; Dooley S; Rudolph KL; Manns MP; Vogel A
Gut; 2014 Sep; 63(9):1501-12. PubMed ID: 24092862
[TBL] [Abstract][Full Text] [Related]
12. B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury.
Faggioli F; Palagano E; Di Tommaso L; Donadon M; Marrella V; Recordati C; Mantero S; Villa A; Vezzoni P; Cassani B
Hepatology; 2018 May; 67(5):1970-1985. PubMed ID: 29105104
[TBL] [Abstract][Full Text] [Related]
13. Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice.
Pusterla T; Nèmeth J; Stein I; Wiechert L; Knigin D; Marhenke S; Longerich T; Kumar V; Arnold B; Vogel A; Bierhaus A; Pikarsky E; Hess J; Angel P
Hepatology; 2013 Jul; 58(1):363-73. PubMed ID: 23504974
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of the chemopreventive effect on hepatocellular carcinoma development in Mdr2 knockout mice.
Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Barash H; Domany E; Galun E; Goldenberg D
Mol Cancer Ther; 2007 Apr; 6(4):1283-91. PubMed ID: 17431106
[TBL] [Abstract][Full Text] [Related]
15. A new Mdr2(-/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer.
Ikenaga N; Liu SB; Sverdlov DY; Yoshida S; Nasser I; Ke Q; Kang PM; Popov Y
Am J Pathol; 2015 Feb; 185(2):325-34. PubMed ID: 25478810
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid aberrancies and hepatocellular carcinoma: studies in the MDR2 gene knockout mouse.
Skill N; Wu J; Xu Y; Zhao Z; Maluccio M
Cancer Invest; 2013 Feb; 31(2):145-55. PubMed ID: 23362952
[TBL] [Abstract][Full Text] [Related]
17. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.
Ogata H; Kobayashi T; Chinen T; Takaki H; Sanada T; Minoda Y; Koga K; Takaesu G; Maehara Y; Iida M; Yoshimura A
Gastroenterology; 2006 Jul; 131(1):179-93. PubMed ID: 16831601
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of 11C-acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma.
Territo PR; Maluccio M; Riley AA; McCarthy BP; Fletcher J; Tann M; Saxena R; Skill NJ
BMC Med Imaging; 2015 May; 15():15. PubMed ID: 25981587
[TBL] [Abstract][Full Text] [Related]
19. Dietary Protective Effects Against Hepatocellular Carcinoma Development in Mdr2-/- Knockout Mice.
Gentileschi MP; Lattanzio C; Menicagli F; Vincenzi B; Cigliana G; Baldi A; Blandino G; Muti P; Fanciulli M; Spugnini EP
In Vivo; 2016; 30(4):445-50. PubMed ID: 27381607
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
